Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S.

Biomed Res Int. 2019 Apr 4;2019:5738614. doi: 10.1155/2019/5738614. eCollection 2019.

2.

Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.

Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S.

Cancers (Basel). 2019 Apr 10;11(4). pii: E514. doi: 10.3390/cancers11040514.

3.

The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.

Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Pancreatology. 2019 Mar;19(2):307-315. doi: 10.1016/j.pan.2019.01.020. Epub 2019 Jan 25.

PMID:
30738764
4.

Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.

Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.

Pancreas. 2019 Feb;48(2):281-291. doi: 10.1097/MPA.0000000000001227.

PMID:
30629019
5.

The Critical Role of Biliary Candidiasis in Development of Surgical Site Infections after Pancreatoduodenectomy: Results of Prospective Study Using a Selective Culture Medium for Candida Species.

Kato H, Iizawa Y, Nakamura K, Gyoten K, Hayasaki A, Fujii T, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuo S, Usui M, Sakurai H, Isaji S.

Biomed Res Int. 2018 Nov 18;2018:5939724. doi: 10.1155/2018/5939724. eCollection 2018.

6.

A case of hepatic anisakiasis caused by Pseudoterranova decipiens mimicking metastatic liver cancer.

Murata Y, Ando K, Usui M, Sugiyama H, Hayashi A, Tanemura A, Kato H, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

BMC Infect Dis. 2018 Dec 4;18(1):619. doi: 10.1186/s12879-018-3540-8.

7.

Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8+ T Cell Responses.

Murata Y, Kawashima K, Sheikh K, Tanaka Y, Isogawa M.

J Virol. 2018 Oct 12;92(21). pii: e00920-18. doi: 10.1128/JVI.00920-18. Print 2018 Nov 1.

8.

Clinical Significance of Histological Effect and Intratumor Stromal Expression of Tenascin-C in Resected Specimens After Chemoradiotherapy for Initially Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma.

Hayasaki A, Murata Y, Usui M, Hibi T, Ito T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Yoshida T, Isaji S.

Pancreas. 2018 Apr;47(4):390-399. doi: 10.1097/MPA.0000000000001022.

PMID:
29517632
9.

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.

Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.

Cancers (Basel). 2018 Mar 5;10(3). pii: E65. doi: 10.3390/cancers10030065.

10.

[I. The Efficacy of Preoperative Adjuvant Treatment for Pancreatic Ductal Adenocarcinoma Based on the Resectability Criteria according to JPS 7th].

Shinkai T, Kato H, Hayasaki A, Murata Y, Kishiwada M, Isaji S.

Gan To Kagaku Ryoho. 2017 Oct;44(10):837-844. Japanese. No abstract available.

PMID:
29066676
11.

Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.

Matsui T, Usui M, Wada H, Iizawa Y, Kato H, Tanemura A, Murata Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Clin Appl Thromb Hemost. 2018 Mar;24(2):254-262. doi: 10.1177/1076029617725600. Epub 2017 Oct 19.

PMID:
29050501
12.

Long-term outcomes after pancreaticoduodenectomy using pair-watch suturing technique: Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction.

Iizawa Y, Kato H, Kishiwada M, Hayasaki A, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H, Isaji S.

Pancreatology. 2017 Sep - Oct;17(5):814-821. doi: 10.1016/j.pan.2017.06.008. Epub 2017 Jun 23.

13.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

Isogawa M, Chung J, Murata Y, Kakimi K, Chisari FV.

PLoS Pathog. 2017 May 31;13(5):e1006416. doi: 10.1371/journal.ppat.1006416. eCollection 2017 May.

14.

Superiority of stapled side-to-side gastrojejunostomy over conventional hand-sewn end-to-side gastrojejunostomy for reducing the risk of primary delayed gastric emptying after subtotal stomach-preserving pancreaticoduodenectomy.

Murata Y, Tanemura A, Kato H, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Surg Today. 2017 Aug;47(8):1007-1017. doi: 10.1007/s00595-017-1504-z. Epub 2017 Mar 23.

15.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

Isogawa M, Chung J, Murata Y, Kakimi K, Chisari FV.

PLoS Pathog. 2016 Dec 7;12(12):e1006086. doi: 10.1371/journal.ppat.1006086. eCollection 2016 Dec.

16.

Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.

Kuriyama N, Isaji S, Tanemura A, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H.

J Gastrointest Surg. 2017 Mar;21(3):590-599. doi: 10.1007/s11605-016-3332-7. Epub 2016 Nov 28.

17.

Negative Impact of Biliary Candidiasis on Early and Late Postoperative Complications After Pancreatoduodenectomy Usefulness of the CHROMagar Candida Plate for Identification.

Kato H, Iizawa Y, Kishiwada M, Usui M, Nakamura A, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Mizuno S, Sakurai H, Isaji S.

Pancreas. 2016 Oct;45(9):e45-7. doi: 10.1097/MPA.0000000000000682. No abstract available.

PMID:
27623557
18.

A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio.

Gyoten K, Mizuno S, Kato H, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplantation. 2016 Oct;100(10):2138-45. doi: 10.1097/TP.0000000000001370.

19.

(1R,2S,6R)-Papayanal: a new male-specific volatile compound released by the guava weevil Conotrachelus psidii (Coleoptera: Curculionidae).

Romero-Frías A, Murata Y, Simões Bento JM, Osorio C.

Biosci Biotechnol Biochem. 2016 May;80(5):848-55. doi: 10.1080/09168451.2015.1136877. Epub 2016 Feb 12.

PMID:
26873673
20.

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.

Yamada R, Mizuno S, Uchida K, Yoneda M, Kanayama K, Inoue H, Murata Y, Kuriyama N, Kishiwada M, Usui M, Ii N, Tsuboi J, Tano S, Hamada Y, Tanaka K, Horiki N, Ogura T, Shiraishi T, Takei Y, Katayama N, Isaji S.

Pancreas. 2016 May-Jun;45(5):761-71. doi: 10.1097/MPA.0000000000000597.

Supplemental Content

Loading ...
Support Center